Stockreport
Why Telix Pharmaceuticals (ASX:TLX) Is Up 13.8% After Regeneron Radiopharma Alliance Announcement And What's Next [Yahoo! Finance]
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
radiopharmaceutical therapies for solid tumors, combining Regeneron's antibody platforms with Telix's manufacturing and distribution network under a cost and profit-sharing model that begins with four programs and includes a US$40 million upfront payment. The agreement gives Telix the flexibility to either co-fund and share global profits or opt for very large potential milestone payments plus royalties, highlighting how its radiopharmaceutical platform can be monetized through different risk-sharing structures across therapeutics and diagnostics. Next, we'll examine how this Regeneron partnership, and its flexible mix of profit-sharing and milestones, could reshape Telix's investment narrative. Capitalize on the AI infrastructure supercycle with our selection of the 37 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow. Telix Pharmaceuticals Investment Narrative Recap To own Telix today, you need to believe its radiopharmac
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | REGN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
REGN alerts
REGN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
REGN alerts
High impacting Regeneron Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
REGN
NEWS
NEWS
- NTLA Stock Rises 20% in 3 Months: Here's What You Should Know [Yahoo! Finance][Yahoo! Finance]
- Regeneron and Telix Announce Strategic Radiopharma Collaboration[GlobeNewswire]
- Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)[GlobeNewswire]
- Telix and Regeneron Announce Strategic Radiopharma Collaboration[PR Newswire]
- Regeneron Pharmaceuticals (REGN) had its price target raised by Morgan Stanley from $769.00 to $796.00. They now have an "equal weight" rating on the stock.[MarketBeat]
- More
REGN
SEC Filings
SEC Filings
- 4/8/26 - Form 8-K
- 4/3/26 - Form 4
- 3/27/26 - Form SCHEDULE
- REGN's page on the SEC website
- More